Detalhe da pesquisa
1.
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
N Engl J Med
; 390(16): 1467-1480, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657244
2.
Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis.
Hematol Oncol
; 41(2): 239-247, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34564882
3.
An Improved Nomogram to Reduce False-Positive Biopsy Rates of Breast Imaging Reporting and Data System Ultrasonography Category 4A Lesions.
Cancer Control
; 29: 10732748221122703, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-37735939
4.
CAR-T Cell Therapy: Advances in Kidney-Related Diseases.
Kidney Dis (Basel)
; 10(2): 143-152, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751795
5.
Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism.
Cell Rep Med
; 5(2): 101400, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307031
6.
Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma.
Front Immunol
; 14: 1125357, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37215107